We are live on ! Find out more
SCR

SIMCERE PHARMACEUTICAL GROUP, ADS
SCR

Delisted

SCR was delisted on the 23rd of December, 2013.

Back to rankings

21 hedge funds and large institutions have $16.6M invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2013 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less call options, than puts

Call options by funds: $133K | Put options by funds: $653K

Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
–
Reduced
–
Closed
–
Calls
$133K
Puts
$653K
Net Calls
-$520K
Net Calls Change
-$520K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$5.68M +$5.54M +599,300 New
SGA
2
Siguler Guff Advisers
New York
$3.25M +$3.17M +342,936 New
PRCM
3
Pine River Capital Management
Minnesota
$2.41M +$2.35M +254,299 New
PCM
4
Pentwater Capital Management
Florida
$2.4M +$2.34M +252,673 New
Invesco
5
Invesco
Georgia
$533K +$521K +56,272 New
EC
6
EJF Capital
Virginia
$464K +$453K +48,994 New
HK
7
Horizon Kinetics
New York
$455K +$444K +48,000 New
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$283K +$278K +30,009 New
Renaissance Technologies
9
Renaissance Technologies
New York
$264K +$257K +27,800 New
Baillie Gifford & Co
10
Baillie Gifford & Co
United Kingdom
$231K +$226K +24,400 New
TD Asset Management
11
TD Asset Management
Ontario, Canada
$214K +$209K +22,600 New
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$185K +$180K +19,500 New
Two Sigma Investments
13
Two Sigma Investments
New York
$99K +$96.2K +10,398 New
Deutsche Bank
14
Deutsche Bank
Germany
$64K +$62.9K +6,800 New
Barclays
15
Barclays
United Kingdom
$30K +$29.7K +3,213 New
U
16
UBS
Switzerland
$22K +$21.3K +2,304 New
Bank of America
17
Bank of America
North Carolina
$20K +$19.5K +2,105 New
Group One Trading
18
Group One Trading
Illinois
$15K +$14.8K +1,600 New
Ameriprise
19
Ameriprise
Minnesota
$7K +$6.63K +716 New
BFA
20
BlackRock Fund Advisors
California
$2K +$2.19K +237 New
Citigroup
21
Citigroup
New York
– +$268 +29 New

SCR Hedge Fund Activity: Q2 2013 in Review

21 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q2 2013, worth a combined $16.6M.

Buyers outnumbered sellers: 21 funds opened new SCR positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

  • 21 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6M of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q2 2013.
  • 21 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q2 2013 and 0 closed out, a net change of +21 holders.

Based on aggregated 13F filings for Q2 2013.